José collaborated with Obesity Medicine colleagues across the US in "Obesity among Latinx people in the United States: A review."https://pubmed.ncbi.nlm.nih.gov/36695058/
José publishes collaboration with the Sibinga group at Einstein on "Increased adipose catecholamine levels and protection from obesity with loss of Allograft Inflammatory Factor-1."https://pubmed.ncbi.nlm.nih.gov/36596796/
José publishes collaboration with the WIHS study, Emory and Cornell on "Plasma metabolomic analysis indicates flavonoids and sorbic acid are associated with incident diabetes: A nested case-control study among Women's Interagency HIV Study participants."https://pubmed.ncbi.nlm.nih.gov/35802662/
Dr. Joanne Bruno in LTOR published "Body weight and prandial variation of plasma metabolites in subjects undergoing gastric band-induced weight loss" in the journal Obesity Medicine!https://pubmed.ncbi.nlm.nih.gov/37216066/
LTOR publishes “Obesity Pharmacotherapy is Effective in the Veterans Affairs Patient Population: A Local and Virtual Cohort Study”https://pubmed.ncbi.nlm.nih.gov/33491308/
José chairs the Obesity and COVID-19 symposium at virtual Obesity Week 2020.https://obesityweek.org/
LTOR collaborates with the Mueller lab at NYU Endocrinology to publish “PPARγ agonists delay age-associated metabolic disease and extend longevity.”https://pubmed.ncbi.nlm.nih.gov/33219735/ https://nyulangone.org/news/researchers-find-new-anti-aging-properties-old-diabetes-drugs
Dr. Aleman is featured on an episode of HCPLive Crisis Point, Burdens of Clinical Care in the Obesity Crisis.
Dr. Jose Aleman is featured by the Veteran's Affairs Office of Research and Development.
LTOR publishes “Obesity Pharmacotherapy is Effective in the Veterans Affairs Patient Population: A Local and Virtual Cohort Study”
José chairs the Obesity and COVID-19 symposium at virtual Obesity Week 2020.
LTOR collaborates with the Mueller lab at NYU Endocrinology to publish “PPARγ agonists delay age-associated metabolic disease and extend longevity.”
LTOR collaborates with Sean Heffron’s group in NYU Cardiology to publish “Lipoprotein insulin resistance score in nondiabetic patients with obesity after bariatric surgery.”
Dr. Aleman discusses his work at NYU School of Medicine Grand Rounds.
LTOR receives grant funding from the National Institutes of Health! K08-DK117064 Metabolic Flux Analysis of Obesity-Associated Inflammation in Weight Loss. The principal goal of this study is to understand the mechanisms by which lipid release from adipocytes modulates systemic and adipose tissue inflammation in human obesity and weight loss.
Franco Vallejo presents a poster at the 3rd NYC Regional Obesity Forum from our early clinical work assessing self-efficacy in medical weight management.
José publishes followup study on fecal microbiota and bile acid effects of diet-induced weight loss.
José is senior author on a collaborative study examining miR-148a in adiponectin sensitivity following bariatric weight loss.
LTOR moves to its new home in NYU Health's new Science Building!
José Alemán interviews with Contigo en la Comunidad. (Spanish)
Andrew Parziale, MD joins the Alemán lab.
LTOR is part of the NYULMC AHA Strategically Focused Obesity Research Network Center.
Akankasha Tiwari joins the Alemán lab as a research affiliate.
Migdalia Reid - Research Coordinator, joins the Alemán lab.
Michael Verano - Lab Technician/Lab Manager, joins the Alemán Lab
José Alemán moves into Alexandria West Tower, room 640.